Psychemedics Corp
NASDAQ:PMD

Watchlist Manager
Psychemedics Corp Logo
Psychemedics Corp
NASDAQ:PMD
Watchlist
Price: 2.67 USD -1.84% Market Closed
Market Cap: $15.7m

Psychemedics Corp
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Psychemedics Corp
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Psychemedics Corp
NASDAQ:PMD
Research & Development
-$855k
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
4%
Quest Diagnostics Inc
NYSE:DGX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guardant Health Inc
NASDAQ:GH
Research & Development
-$359.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
No Stocks Found

Psychemedics Corp
Glance View

Market Cap
15.7m USD
Industry
Health Care

Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. The company is headquartered in Acton, Massachusetts and currently employs 139 full-time employees. The firm provides testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. The firm customize its enzyme immunoassay (EIA) procedures to drug test hair samples. The firm provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phenylcyclohexyl piperidine (PCP), amphetamines, opiates, synthetic cannabinoids, benzodiazepines, nicotine and fentanyl. The firm markets its corporate drug testing services through its own sales force, distributors and webinars. The firm markets its home drug testing service, PDT-90, through the Internet.

PMD Intrinsic Value
3.25 USD
Undervaluation 18%
Intrinsic Value
Price

See Also

What is Psychemedics Corp's Research & Development?
Research & Development
-855k USD

Based on the financial report for Sep 30, 2024, Psychemedics Corp's Research & Development amounts to -855k USD.

What is Psychemedics Corp's Research & Development growth rate?
Research & Development CAGR 10Y
4%

Over the last year, the Research & Development growth was 28%. The average annual Research & Development growth rates for Psychemedics Corp have been 8% over the past three years , 13% over the past five years , and 4% over the past ten years .

Back to Top